Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROPRADO traumatic memory reconsolidation in adolescent PTSD
2020-001878-29Phase 3Active
- Sponsor
- CHU Rennes
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in post-traumatic stress disorder (PTSD) comparing Propranolol arm with Placebo arm (2 arms). Primary endpoint: PTSD symptom severity (primary). Started Nov 2020; status: active.
02
Drugs
propranolol
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on 2020-001878-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001878-29.